Tag: biotech stocks
Why The Biotech Sector ETF (IBB) Is “Distributing” Pain
A few days ago I tweeted that the iShares Nasdaq Biotechnology ETF (IBB) looked to have entered a period of clear “distribution”, meaning that...
Caution: These Two Key Market Leaders May Be Topping
I am a big believer in following market leaders for both investment prospects and indicators. As investments, they can bring big profits. And as...
Biotech Sector (IBB): The Anatomy Of A “Blow Off” Top
Recent price action in the Biotech Sector ETF (IBB) and select biotech stocks has attracted a lot of attention and with good reason: it...
The Amazing Run In Biotech Stocks
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty...
Will Gilead Sciences Stock (GILD) Take Biotech Higher?
Perhaps the two hottest themes in the markets right are the move in the US Dollar and what is going on in the Biotech...
ETFs In Focus: Shift In RSI Weakens Biotech Sector (IBB)
We can use the Relative Strength Index (RSI) in a myriad of ways, but my favorite way is to use it as a straight...
Is A Sharp Move Coming For Biotech Stocks?
There are some signs that biotech wants to get moving here, making it an important sector to watch in the coming days and weeks.
Before...
Biotech Buyouts Boost Sector ETFs
Biotech buyouts may be en vogue again. Nothing exemplifies this more than the recent buyout of Idenix Pharmaceuticals (IDIX) by drug maker Merck & Co...
Celgene (CELG) At Technical Crossroads
Despite the excitement surrounding the S&P 500 briefly touching all-time highs on Monday, the market has yet to demonstrate proper follow-thru or confirmation that...
Biotech IPOs: New Market Paradigm or Nearing a Cliff?
Within the last 6 months, 22 Biotech IPOs have occurred in the US. Though that may seem modest in a market populated by thousands...
